4 results match your criteria: "Pediatric Clinical Medical Research Center of Guangxi[Affiliation]"

The association between systemic immune-inflammation index (SII) and early nosocomial infections after cardiopulmonary bypass surgery in children with congenital heart disease.

BMC Cardiovasc Disord

December 2024

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University/Difficult and Critical Illness Center, Pediatric Clinical Medical Research Center of Guangxi, Nanning, 530022, China.

Background: Infections occurring postoperatively in pediatric patients with congenital heart disease (CHD) following cardiopulmonary bypass (CPB) surgery pose a considerable challenge, affecting the duration of hospitalization, financial costs, and patient outcomes. Studies investigating the association between systemic immune-inflammation index (SII) and early infections after CHD surgery are very rare. This study seeks to delineate the link between SII and the occurrence of early nosocomial infections in pediatric patients undergoing CPB surgery for CHD.

View Article and Find Full Text PDF

Background: The reported outcomes of pediatric dilated cardiomyopathy (DCM) have varied across studies. There are few outcome data concerning DCM in Chinese children. Therefore, we conducted a retrospective study to describe clinical features and determine risk factors for poor outcomes in children with DCM.

View Article and Find Full Text PDF

Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury.

Eur J Clin Pharmacol

September 2024

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Difficult and Critical illness Center, Pediatric Clinical Medical Research Center of Guangxi, Nanning, Guangxi Zhuang Autonomous Region, China.

Purpose: To summarize the clinical and biochemical characteristics of patients with ceftriaxone-induced liver injury and guide the selection of safe medication.

Methods: Retrieved domestic and foreign databases from inception to October 2023, collected case data conforming to ceftriaxone-induced liver injury, and statistically analyzed the data.

Results: A total of 617 articles were retrieved, and 16 articles with 33 cases (10 children, 23 adults) were included.

View Article and Find Full Text PDF

A case report of classic galactosemia with a GALT gene variant and a literature review.

BMC Pediatr

May 2024

Difficult and Critical Illness Center, Pediatric Clinical Medical Research Center of Guangxi, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Nanning, 530021, Guangxi Zhuang Autonomous Region, China.

Background: Galactosemia is an autosomal recessive disorder resulting from an enzyme defect in the galactose metabolic pathway. The most severe manifestation of classic galactosemia is caused by galactose-1-phosphate uridylyltransferase (GALT) deficiency, and this condition can be fatal during infancy if left untreated. It also may result in long-term complications in affected individuals.

View Article and Find Full Text PDF